Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial
0
Authors
Juleen Gayed
11 more
Juleen Gayed
•
Vishva Bangad
9 more
•
Nicholas Kitchin
Published
July 2, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Vaccines
Topics
Chemistry
Immunology
Medicine
Internal Medicine
Organic Chemistry
Show all topics
DOI
10.3390/vaccines12070734
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Vaccines
Topics
Chemistry
Immunology
Medicine
Internal Medicine
Organic Chemistry
Show all topics
DOI
10.3390/vaccines12070734
License
CC-BY
